THROMBOCYTOPENIA AND IMPAIRED KIDNEY FUNCTION ARE MAJOR RISK FACTORS FOR RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

被引：0
|
作者：
Karandyszowska, N. [1 ,2 ]
Alagunduz, H. [1 ]
Widaeus, J. [1 ]
Carlens, F. [3 ]
Warnqvist, A. [4 ]
Magnussion, M. [2 ,5 ,6 ]
Gunnarsson, I. [7 ]
Svenungsson, E. [7 ]
Bruzelius, M. [1 ,2 ]
Antovic, A. [7 ]
机构：
[1] Karolinska Inst, Dept Med Solna, Stockholm, Sweden
[2] Karolinska Sjukhuset Solna, Dept Hematol, Coagulat Unit, Stockholm, Sweden
[3] Orebro Univ, Sch Med Sci, Orebro, Sweden
[4] Karolinska Inst, Inst Environm Med, Div Biostat, Stockholm, Sweden
[5] Karolinska Inst, CLINTEC, Stockholm, Sweden
[6] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[7] Karolinska Inst, Dept Med Solna, Div Rheumatol, Karolinska Univ Hosp,Rheumatol, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Epidemiology; Anti-phospholipid syndrome;
D O I：
10.1136/annrheumdis-2023-eular.4437
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1512
引用
收藏
页码：1115 / 1115
页数：1
相关论文
共 50 条
  • [41] Factors related to the risk of thrombosis in patients with lupus antiphospholipid antibodies and
    Martinez, Fernando
    Forner, Maria Jose
    Ruano, Maria
    Abdilla, Noelia
    Oltra, Rosa
    Garcia-Fuster, Maria Jose
    MEDICINA CLINICA, 2006, 127 (11): : 405 - 408
  • [42] Anticardiolopin antibodies as thrombosis risk factors in the treated patients with antiphospholipid
    Haroyan, A.
    Mkrtchyan, N.
    Tokhunts, K.
    Galstyan, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 145 - 145
  • [43] Right Atrial Thrombosis in Antiphospholipid Syndrome with Secondary Immune Thrombocytopenia
    Voigtlaender, Minna
    Conradi, Lenard
    Hinsch, Andrea
    Langer, Florian
    THORACIC AND CARDIOVASCULAR SURGEON REPORTS, 2015, 4 (01): : 40 - 43
  • [44] Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?
    Yelnik, Cecile M.
    Yann Nguyen
    Le Guern, Veronique
    Hachulla, Eric
    Lambert, Marc
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 106 - 107
  • [45] Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopenia
    Moulinet, Thomas
    Dufrost, Virginie
    Clerc-Urmes, Isabelle
    Wahl, Denis
    Zuily, Stephane
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 84 : 101 - 103
  • [46] Antiphospholipid antibody-associated thrombocytopenia and the paradoxical risk of thrombosis
    Fortea, J
    Obach, V
    Cervera, R
    Gamarra, AI
    LUPUS, 2006, 15 (01) : 58 - 58
  • [47] Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome
    Hsiao, GR
    Wolf, RE
    Kimpel, DL
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (05) : 336 - 339
  • [48] Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome
    del-Pino, Rodrigo Aguirre
    Monahan, Rory C.
    Huizinga, Tom W. J.
    Eikenboom, Jeroen
    Steup-Beekman, Gerda M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06): : 817 - 828
  • [49] Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management
    Scheen, Marc
    Adedjouma, Amir
    Esteve, Emmanuel
    Buob, David
    Abisror, Noemie
    Planche, Virginie
    Fain, Olivier
    Boffa, Jean Jacques
    De Seigneux, Sophie
    Mekinian, Arsene
    Haidar, Fadi
    AUTOIMMUNITY REVIEWS, 2022, 21 (05)
  • [50] Confusion in the classification of antiphospholipid syndrome in patients with thrombocytopenia
    Atsumi, T
    Koike, T
    INTERNAL MEDICINE, 1998, 37 (09) : 796 - 797
12345